The Nijmegen ultra-sensitive Bethesda Assay detects very low-titer factor VIII inhibitors in patients with congenital and acquired hemophilia A.
Valke LLFG, Verhagen MJA, Mulders BTPM, Polenewen R, Blijlevens NMA, Jansen JH, Mansouritorghabeh H, Elsheikh E, Reipert BM, Turecek PL, O'Donnell JS, Rijpma SR, Schols SEM, van Heerde WL, Meijer D.
Valke LLFG, et al.
Thromb Res. 2023 Nov;231:112-120. doi: 10.1016/j.thromres.2023.10.007. Epub 2023 Oct 11.
Thromb Res. 2023.
PMID: 37844518